Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review

Methylenedioxymethamphetamine (MDMA) is a psychoactive substance that is used commonly as a recreational drug at rave music festivals. MDMA intoxication can cause a myriad of symptoms and side effects including the manifestation of hyperpyrexia in patients. Hyperpyrexia can mimic a heat stroke and u...

Full description

Saved in:
Bibliographic Details
Main Authors: Kia Nikoomanesh, Alexander T. Phan, Julian Choi, Sarkis Arabian, Michael M. Neeki
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2022/5346792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850215429212995584
author Kia Nikoomanesh
Alexander T. Phan
Julian Choi
Sarkis Arabian
Michael M. Neeki
author_facet Kia Nikoomanesh
Alexander T. Phan
Julian Choi
Sarkis Arabian
Michael M. Neeki
author_sort Kia Nikoomanesh
collection DOAJ
description Methylenedioxymethamphetamine (MDMA) is a psychoactive substance that is used commonly as a recreational drug at rave music festivals. MDMA intoxication can cause a myriad of symptoms and side effects including the manifestation of hyperpyrexia in patients. Hyperpyrexia can mimic a heat stroke and ultimately lead to various forms of end-organ damage. The most common methods used in treating MDMA-induced hyperpyrexia focus on the rapid reduction of core body temperature. Various off-label medications have also been used in combating MDMA-induced hyperpyrexia. Dantrolene is one such medication, although its role in the treatment of MDMA intoxication remains uncertain. This case series preliminarily examines the efficacy of dantrolene in mitigating MDMA-induced hyperpyrexia and potentially reducing the risk of end-organ damage in patients suffering from MDMA overdose. This study focuses on nine patients who presented after ingesting various forms of MDMA at “rave” music events. All patients were found to be hyperthermic in the field with a maximum core body temperature of 109 degrees Fahrenheit. All patients were immediately managed by cooling measures, and seven patients additionally received dantrolene in the field before being transferred to Arrowhead Regional Medical Center. Upon arrival to the hospital, nearly every patient was found to have significantly decreased body temperatures when compared to previously measured body temperatures out in the field. However, nearly all patients in the study were also noted to have laboratory abnormalities consistent with various forms of end-organ damage. The degree and severity of end-organ damage observed in MDMA-induced hyperpyrexia seem to be a function of initial core body temperature. Higher core body temperature tends to correlate with more forms of end-organ damage and a higher severity of end-organ damage. Intervention with dantrolene and cooling measures appeared to have no effect on reducing the risk of developing end-organ damage in this patient population.
format Article
id doaj-art-7fdb0366d4f54298b57906c449a16b28
institution OA Journals
issn 2090-6439
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Critical Care
spelling doaj-art-7fdb0366d4f54298b57906c449a16b282025-08-20T02:08:36ZengWileyCase Reports in Critical Care2090-64392022-01-01202210.1155/2022/5346792Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature ReviewKia Nikoomanesh0Alexander T. Phan1Julian Choi2Sarkis Arabian3Michael M. Neeki4Department of Critical Care MedicineCalifornia University of Science and MedicineDepartment of Critical Care MedicineDepartment of Critical Care MedicineCalifornia University of Science and MedicineMethylenedioxymethamphetamine (MDMA) is a psychoactive substance that is used commonly as a recreational drug at rave music festivals. MDMA intoxication can cause a myriad of symptoms and side effects including the manifestation of hyperpyrexia in patients. Hyperpyrexia can mimic a heat stroke and ultimately lead to various forms of end-organ damage. The most common methods used in treating MDMA-induced hyperpyrexia focus on the rapid reduction of core body temperature. Various off-label medications have also been used in combating MDMA-induced hyperpyrexia. Dantrolene is one such medication, although its role in the treatment of MDMA intoxication remains uncertain. This case series preliminarily examines the efficacy of dantrolene in mitigating MDMA-induced hyperpyrexia and potentially reducing the risk of end-organ damage in patients suffering from MDMA overdose. This study focuses on nine patients who presented after ingesting various forms of MDMA at “rave” music events. All patients were found to be hyperthermic in the field with a maximum core body temperature of 109 degrees Fahrenheit. All patients were immediately managed by cooling measures, and seven patients additionally received dantrolene in the field before being transferred to Arrowhead Regional Medical Center. Upon arrival to the hospital, nearly every patient was found to have significantly decreased body temperatures when compared to previously measured body temperatures out in the field. However, nearly all patients in the study were also noted to have laboratory abnormalities consistent with various forms of end-organ damage. The degree and severity of end-organ damage observed in MDMA-induced hyperpyrexia seem to be a function of initial core body temperature. Higher core body temperature tends to correlate with more forms of end-organ damage and a higher severity of end-organ damage. Intervention with dantrolene and cooling measures appeared to have no effect on reducing the risk of developing end-organ damage in this patient population.http://dx.doi.org/10.1155/2022/5346792
spellingShingle Kia Nikoomanesh
Alexander T. Phan
Julian Choi
Sarkis Arabian
Michael M. Neeki
Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
Case Reports in Critical Care
title Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
title_full Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
title_fullStr Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
title_full_unstemmed Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
title_short Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review
title_sort dantrolene administration in the management of the prehospital patient with methylenedioxymethamphetamine overdose a case series and literature review
url http://dx.doi.org/10.1155/2022/5346792
work_keys_str_mv AT kianikoomanesh dantroleneadministrationinthemanagementoftheprehospitalpatientwithmethylenedioxymethamphetamineoverdoseacaseseriesandliteraturereview
AT alexandertphan dantroleneadministrationinthemanagementoftheprehospitalpatientwithmethylenedioxymethamphetamineoverdoseacaseseriesandliteraturereview
AT julianchoi dantroleneadministrationinthemanagementoftheprehospitalpatientwithmethylenedioxymethamphetamineoverdoseacaseseriesandliteraturereview
AT sarkisarabian dantroleneadministrationinthemanagementoftheprehospitalpatientwithmethylenedioxymethamphetamineoverdoseacaseseriesandliteraturereview
AT michaelmneeki dantroleneadministrationinthemanagementoftheprehospitalpatientwithmethylenedioxymethamphetamineoverdoseacaseseriesandliteraturereview